Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 4, 2011, Pages 1181-1188

  Kasten Pisula, Ulla ^a   Saker, Jarob ^a   Eicheler, Wolfgang ^b,c   Krause, Mechthild ^b,c   Yaromina, Ala ^b,c   Meyer Staeckling, Sönke ^a   Scherkl, Benjamin ^a   Kriegs, Malte ^a   Brandt, Burkhard ^a   Grénman, Reidar ^d   Petersen, Cordula ^a   Baumann, Michael ^b,c   Dikomey, Ekkehard ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c Helmholtz Zentrum Dresden Rossendorf   (Germany)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Biomarker; Epidermal growth factor receptor; Local tumor control; Radiotherapy; Squamous cell carcinoma

Indexed keywords

CELL LINES; CELLULAR RADIOSENSITIVITY; COLONY FORMATION; CONFLICTING EVIDENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR RECEPTORS; FRACTIONATED IRRADIATION; GENE AMPLIFICATION; HUMAN TUMORS; IN-VITRO; IN-VIVO; LOCAL TUMOR CONTROL; NUDE MICE; PROTEIN EXPRESSIONS; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINES; TUMOR CONTROL; UP-REGULATION; WESTERN BLOTS;

ANIMAL CELL CULTURE; CELLS; GENE EXPRESSION; IRRADIATION; MAMMALS; PEPTIDES; POLYMERASE CHAIN REACTION;

TUMORS;

EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CELL LINE; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE DOSAGE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRON; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; GENE AMPLIFICATION; GENES, ERBB-1; HUMANS; INTRONS; MICE; MICE, NUDE; RADIATION TOLERANCE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79959327176     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.043     Document Type: Article

References (44)

1. K.K. Ang, B.A. Berkey, and X. Tu Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356 (Pubitemid 36025259)
2. J. Thariat, L. Milas, and K.K. Ang Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer Int J Radiat Oncol Biol Phys 69 2007 974 984 (Pubitemid 47625860)
3. S.M. Huang, and P.M. Harari Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis Clin Cancer Res 6 2000 2166 2174 (Pubitemid 30399181)
4. M. Baumann, M. Krause, and E. Dikomey EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanisms Radiother Oncol 83 2007 238 248 (Pubitemid 46915540)
5. M. Baumann, and M. Krause Targeting the epidermal growth factor receptor in radiotherapy: Radiobiological mechanisms, preclinical and clinical results Radiother Oncol 72 2004 257 266 (Pubitemid 39265378)
6. M. Zimmermann, A. Zouhair, and D. Azria The epidermal growth factor receptor (EGFR) in head and neck cancer: Its role and treatment implications Radiat Oncol 1 2006 11
7. C.M. West, L. Joseph, and S. Bhana Epidermal growth factor receptor-targeted therapy Br J Radiol 81 Spec No 1 2008 S36 S44
8. D.M. Aebersold, S.C. Froehlich, and M. Jonczy Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy Radiother Oncol 63 2002 275 283 (Pubitemid 34874555)
9. A. Chakravarti, K. Winter, and C.L. Wu Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 62 2005 309 317 (Pubitemid 40704444)
10. D. Zips, M. Krause, and A. Yaromina Epidermal growth factor receptor inhibitors for radiotherapy: Biological rationale and preclinical results J Pharm Pharmacol 60 2008 1019 1028
11. S.M. Bentzen, B.M. Atasoy, and F.M. Daley Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial J Clin Oncol 23 2005 5560 5567
12. J.G. Eriksen, T. Steiniche, and J. Overgaard The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study Radiother Oncol 74 2005 93 100 (Pubitemid 40331865)
13. T. Akimoto, N.R. Hunter, and L. Buchmiller Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas Clin Cancer Res 5 1999 2884 2890 (Pubitemid 29493967)
14. I. Szumiel Epidermal growth factor receptor and DNA double strand break repair: The cell's self-defence Cell Signal 18 2006 1537 1548 (Pubitemid 44216136)
15. U. Kasten-Pisula, H. Tastan, and E. Dikomey Huge differences in cellular radiosensitivity due to only very small variations in double-strand break repair capacity Int J Radiat Biol 81 2005 409 419 (Pubitemid 41657557)
16. E. Dikomey, and I. Brammer Relationship between cellular radiosensitivity and non-repaired double-strand breaks studied for different growth states, dose rates and plating conditions in a normal human fibroblast line Int J Radiat Biol 76 2000 773 781 (Pubitemid 30352760)
17. K. Dittmann, C. Mayer, and B. Fehrenbacher Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase J Biol Chem 280 2005 31182 31189 (Pubitemid 41291855)
18. S.E. Golding, R.N. Morgan, and B.R. Adams Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells Cancer Biol Ther 8 2009 730 738
19. M. Kriegs, U. Kasten-Pisula, and T. Rieckmann The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining DNA Repair (Amst) 9 2010 889 897
20. M. Toulany, U. Kasten-Pisula, and I. Brammer Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair Clin Cancer Res 12 2006 4119 4126 (Pubitemid 44078101)
21. A. Yaromina, M. Krause, and H. Thames Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation Radiother Oncol 83 2007 304 310 (Pubitemid 46915546)
22. H. Buerger, J. Packeisen, and A. Boecker Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence: First results of an inter-ethnic breast cancer study J Pathol 203 2004 545 550 (Pubitemid 38529034)
23. N. Tidow, A. Boecker, and H. Schmidt Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development Cancer Res 63 2003 1172 1178 (Pubitemid 36348690)
24. B. Brandt, U. Vogt, and C.M. Schlotter Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: Double-differential polymerase chain reaction (ddPCR) for clinical diagnosis Gene 159 1995 35 42
25. H. Buerger, F. Gebhardt, and H. Schmidt Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression Cancer Res 60 2000 854 857 (Pubitemid 30129514)
26. G. Bowers, D. Reardon, and T. Hewitt The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells Oncogene 20 2001 1388 1397 (Pubitemid 32269943)
27. M.C. Etienne-Grimaldi, S. Pereira, and N. Magne Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients Ann Oncol 16 2005 934 941 (Pubitemid 40903920)
28. W. Liu, F. Innocenti, and M.H. Wu A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter Cancer Res 65 2005 46 53 (Pubitemid 40070794)
29. A. Bheda, K.E. Creek, and L. Pirisi Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes Oncogene 27 2008 4315 4323 (Pubitemid 352009996)
30. R.J. Webster, K.M. Giles, and K.J. Price Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7 J Biol Chem 284 2009 5731 5741
31. C. Petersen, D. Zips, and M. Krause Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation Int J Radiat Oncol Biol Phys 51 2001 483 493 (Pubitemid 32884296)
32. V. Quennet, A. Yaromina, and D. Zips Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice Radiother Oncol 81 2006 130 135 (Pubitemid 44780779)
33. U.G. Sattler, S.S. Meyer, and V. Quennet Glycolytic metabolism and tumour response to fractionated irradiation Radiother Oncol 94 2010 102 109
34. A. Yaromina, H. Thames, and X. Zhou Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation Radiother Oncol 96 2010 116 122
35. A. Yaromina, T. Holscher, and W. Eicheler Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma? Radiother Oncol 76 2005 206 212 (Pubitemid 41725449)
36. J.G. Eriksen, F.M. Buffa, and J. Alsner Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas Radiother Oncol 72 2004 275 282 (Pubitemid 39265380)
37. F.M. Buffa, S.M. Bentzen, and F.M. Daley Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy Clin Cancer Res 10 2004 3745 3754 (Pubitemid 38697608)
38. D.J. Chen, and C.S. Nirodi The epidermal growth factor receptor: A role in repair of radiation-induced DNA damage Clin Cancer Res 13 2007 6555 6560 (Pubitemid 350206788)
39. Y. Tanaka, S. Miyamoto, and S.O. Suzuki Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer Clin Cancer Res 11 2005 4783 4792 (Pubitemid 41557199)
40. H. Shigeishi, K. Higashikawa, and M. Hiraoka Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas Oncol Rep 19 2008 1557 1564
41. H.P. Rodemann, K. Dittmann, and M. Toulany Radiation-induced EGFR-signaling and control of DNA-damage repair Int J Radiat Biol 83 2007 781 791 (Pubitemid 350219102)
42. J.B. Vermorken, R. Mesia, and F. Rivera Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 2008 1116 1127
43. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
44. Y. Akashi, I. Okamoto, and T. Iwasa Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status Br J Cancer 98 2008 749 755 (Pubitemid 351272610)